Historical record - last NADAC effective date: 3/18/2020
Product Information
RANITIDINE 150 MG CAPSULE is a generic product labeled by Ajanta Pharma USA Inc., priced at $0.3767 per EA under NDC 27241010950. Its NADAC has been published 107 times since Feb 27, 2019.
FDA first approved this application on Sep 27, 2018.
The High Outlier badge above means this manufacturer's average price in the Ranitidine market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
150 mg/1
Manufacturer
Ajanta Pharma USA Inc.NDC
27241010950
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
3/18/2020
Active Ingredients
RANITIDINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA209859FDA Approved
9/27/2018
On Market Since
9/27/2018
Pharmacological Classes
Price Statistics
The NADAC for RANITIDINE 150 MG CAPSULE has been published 107 times since Feb 27, 2019, and over the history we have for it it has declined 23.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3767 per EA |
|---|---|
| All-time high | $0.4938 (Mar 13, 2019) |
| All-time low | $0.2581 (Dec 18, 2019) |
| Median price | $0.3767 |
| Average price | $0.3734 |
| Largest weekly change | -38.3% (Apr 17, 2019) |
| Weeks tracked | 107 |
| Tracking since | Feb 27, 2019 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
-23.7%
Last surveyed Mar 10, 2021 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Ajanta Pharma USA Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Ranitidine market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Histamine-2 Receptor Antagonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of RANITIDINE 150 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for RANITIDINE 150 MG CAPSULE, manufactured by Ajanta Pharma USA Inc., is $0.3767 per EA (NDC 27241010950), effective Mar 10, 2021.
How has the price of RANITIDINE 150 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for RANITIDINE 150 MG CAPSULE has declined 23.7%. It has been tracked across 107 weekly CMS publications since Feb 27, 2019.
What are the highest and lowest recorded NADAC prices for RANITIDINE 150 MG CAPSULE?
Since Feb 27, 2019, the NADAC for RANITIDINE 150 MG CAPSULE has ranged from a low of $0.2581 (Dec 18, 2019) to a high of $0.4938 (Mar 13, 2019), with a median of $0.3767 per EA.
Are there cheaper alternatives to RANITIDINE 150 MG CAPSULE?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as RANITIDINE 150 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures RANITIDINE 150 MG CAPSULE?
RANITIDINE 150 MG CAPSULE (NDC 27241010950) is labeled by Ajanta Pharma USA Inc., and CMS classifies it as a generic product.